ZYNLONTA was generally well tolerated and safety was consistent with known profile . LAUSANNE, Switzerland, June 16, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage ...

Zynlonta’s dosage amount may vary depending on your cancer treatment schedule. Zynlonta is typically given in cycles that last 3 weeks. It’s given on the first day of each cycle.

Zynlonta infusions are usually given at a hospital, doctor’s office, infusion center, or clinic. They’re prepared and administered by a healthcare professional as an IV infusion.

Zynlonta is a prescription drug used to treat certain types of large B-cell lymphoma. Learn about the common, mild, and serious side effects it can cause and how to manage them.

Zynlonta can cause side effects that range from mild to serious. Examples include tiredness, nausea, and diarrhea. Specifically, Zynlonta is used to treat the following kinds of B-cell lymphoma in ...

Zynlonta is supplied in a single-dose vial containing 10mg of loncastuximab tesirine-lpyl as a lyophilized powder for intravenous infusion after reconstitution and further dilution.

ZYNLONTA™ (loncastuximab tesirine-lpyl) Now Approved for the Treatment of Adult Patients with Relapsed/Refractory Large B Cell Lymphoma After Two or More Lines of Systemic Therapy .

ZYNLONTA is a CD19-directed antibody drug conjugate (ADC). Once bound to a CD19-expressing cell, ZYNLONTA is internalized by the cell, where enzymes release a pyrrolobenzodiazepine (PBD) payload.